Doctors 4 Building Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.37 M
as on 12-12-2024
- Revenue -26.88%
(FY 2022)
- Profit -102.99%
(FY 2022)
- Ebitda -62.27%
(FY 2022)
- Net Worth -0.53%
(FY 2022)
- Total Assets -34.62%
(FY 2022)
About Doctors 4 Building
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.37 M.
Sufia Sultana and Tabish Khan serve as directors at the Company.
- CIN/LLPIN
U74900DL2013PTC252607
- Company No.
252607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Doctors 4 Building Private Limited offer?
Doctors 4 Building Private Limited offers a wide range of products and services, including Interior and Exterior Painting Service, Industrial Wall Painting Service, Waterproofing Service, Roof Waterproofing Services, Toilet Waterproofing Services, Epoxy Flooring Services, Industrial Epoxy Flooring Service, Commercial Painting Service, Painting Contractor, Architectural & Civil Engineering.
Who are the key members and board of directors at Doctors 4 Building?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sufia Sultana  | Director | 01-Oct-2018 | Current |
| Tabish Khan | Director | 24-May-2013 | Current |
Financial Performance of Doctors 4 Building.
Doctors 4 Building Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.88% decrease. The company also saw a substantial fall in profitability, with a 102.99% decrease in profit. The company's net worth dipped by a decrease of 0.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctors 4 Building?
In 2020, Doctors 4 Building had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Aug 2018 | ₹2.37 M | Open |
How Many Employees Work at Doctors 4 Building?
Unlock and access historical data on people associated with Doctors 4 Building, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctors 4 Building, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctors 4 Building's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
